IL6 and breast carcinoma: Elevated levels of IL-6 in the plasma of obese rodents compared with lean rats sensitized breast cancer cells to reduced testosterone levels (Fig. 8C),198 demonstrating how cytokines and growth factors associated with obesity can influence the response of breast cancer tumors to steroid hormones and hormonal therapy, regardless of subtypes.